These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2760121)

  • 1. Theophylline pharmacokinetics in patients with bronchopulmonary dysplasia.
    Nahata MC; Serafini D; Edwards R
    J Clin Pharm Ther; 1989 Jun; 14(3):225-9. PubMed ID: 2760121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal theophylline neurotoxicity.
    Clancy RR; Kaplan KM; Baumgart S; Rosenberry KR
    Clin Pediatr (Phila); 1985 Mar; 24(3):168-70. PubMed ID: 3971645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia.
    Kao LC; Durand DJ; Phillips BL; Nickerson BG
    J Pediatr; 1987 Sep; 111(3):439-44. PubMed ID: 3305850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving pulmonary function does not decrease oxygen consumption in infants with bronchopulmonary dysplasia.
    Kao LC; Durand DJ; Nickerson BG
    J Pediatr; 1988 Apr; 112(4):616-21. PubMed ID: 3351689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of theophylline in infants with bronchiolitis.
    Franko TG; Powell DA; Nahata MC
    Eur J Clin Pharmacol; 1982; 23(2):123-7. PubMed ID: 7140801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
    Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R
    Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophylline.
    Nix DE; Di Cicco RA; Miller AK; Boyle DA; Boike SC; Zariffa N; Jorkasky DK; Schentag JJ
    J Clin Pharmacol; 1999 Aug; 39(8):855-65. PubMed ID: 10434239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of theophylline in neonates as an aid to ventilator weaning.
    Capers CC; Ward ES; Murphy JE; Job ML; Land PA
    Ther Drug Monit; 1992 Dec; 14(6):471-4. PubMed ID: 1485368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in theophylline metabolism during the first year of life.
    Kraus DM; Fischer JH; Reitz SJ; Kecskes SA; Yeh TF; McCulloch KM; Tung EC; Cwik MJ
    Clin Pharmacol Ther; 1993 Oct; 54(4):351-9. PubMed ID: 8222476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
    Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
    J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia.
    Yılmaz C; Köksal N; Özkan H; Dorum BA; Bağcı O
    Turk J Pediatr; 2017; 59(2):122-129. PubMed ID: 29276864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic evaluation of two theophylline dosing methods for infants.
    Kraus DM; Hatzopoulos FK; Reitz SJ; Fischer JH
    Ther Drug Monit; 1994 Jun; 16(3):270-6. PubMed ID: 8085281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline improves lipopolysaccharide-induced alveolarization arrest through inflammatory regulation.
    He H; Chen F; Ni W; Li J; Zhang Y
    Mol Med Rep; 2014 Jul; 10(1):269-75. PubMed ID: 24788885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The population pharmacokinetics of theophylline in neonates and young infants.
    Moore ES; Faix RG; Banagale RC; Grasela TH
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):47-66. PubMed ID: 2715932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia.
    Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG
    Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of three theophylline dosing equations for use in infants up to one year of age.
    Hogue SL; Phelps SJ
    J Pediatr; 1993 Oct; 123(4):651-6. PubMed ID: 8192745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Slow-release theophylline for the treatment of asthmatic children].
    Iwasaki E; Baba M
    Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic breathing in preterm infants: influence of bronchopulmonary dysplasia and theophylline.
    Glotzbach SF; Tansey PA; Baldwin RB; Ariagno RL
    Pediatr Pulmonol; 1989; 7(2):78-81. PubMed ID: 2797924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin 1 as a predictor marker for bronchopulmonary dysplasia in preterm neonates with respiratory distress syndrome.
    El Shemi MS; Tawfik S; Khafagy SM; Hamza MT; Youssef AM
    J Neonatal Perinatal Med; 2017; 10(1):79-83. PubMed ID: 28304322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.